Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16384 | 656 | 40.4 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
668 | 3 | ENDOTHELIN//ENDOTHELIN 1//ENDOTHELIN RECEPTORS | 9913 |
1078 | 2 | ENDOTHELIN//ENDOTHELIN 1//ENDOTHELIN RECEPTORS | 9913 |
16384 | 1 | MOL PATHOL ULTRASTRUCT//ENDOTHELIN AXIS//ZIBOTENTAN | 656 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MOL PATHOL ULTRASTRUCT | address | 1163653 | 5% | 83% | 30 |
2 | ENDOTHELIN AXIS | authKW | 523641 | 2% | 75% | 15 |
3 | ZIBOTENTAN | authKW | 455336 | 2% | 65% | 15 |
4 | ATRASENTAN | authKW | 447666 | 4% | 42% | 23 |
5 | ZD4054 | authKW | 394269 | 2% | 71% | 12 |
6 | ENDOTHELIN A RECEPTOR | authKW | 362417 | 4% | 27% | 29 |
7 | MOL NEUROBIOL PAIN | address | 285096 | 1% | 88% | 7 |
8 | BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE | authKW | 279279 | 1% | 100% | 6 |
9 | ETAR | authKW | 211564 | 2% | 45% | 10 |
10 | ENDOTHELIN 1 | authKW | 203747 | 20% | 3% | 133 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2305 | 32% | 0% | 207 |
2 | Pharmacology & Pharmacy | 663 | 20% | 0% | 134 |
3 | Medicine, Research & Experimental | 386 | 10% | 0% | 66 |
4 | Neurosciences | 169 | 12% | 0% | 77 |
5 | Urology & Nephrology | 123 | 5% | 0% | 31 |
6 | Anesthesiology | 120 | 3% | 0% | 19 |
7 | Pathology | 88 | 4% | 0% | 26 |
8 | Endocrinology & Metabolism | 74 | 5% | 0% | 35 |
9 | Cell Biology | 49 | 7% | 0% | 43 |
10 | Clinical Neurology | 40 | 5% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL PATHOL ULTRASTRUCT | 1163653 | 5% | 83% | 30 |
2 | MOL NEUROBIOL PAIN | 285096 | 1% | 88% | 7 |
3 | TRANSLAT FUNCT AREA | 193942 | 1% | 83% | 5 |
4 | BIOENGN NEUROL REHABIL MED | 186186 | 1% | 100% | 4 |
5 | SENSORY NEUROPHYSIOL | 145454 | 1% | 63% | 5 |
6 | CANC INFECT DISCOVERY MED | 104728 | 0% | 75% | 3 |
7 | MOL PATHOL A | 104728 | 0% | 75% | 3 |
8 | 42R | 46547 | 0% | 100% | 1 |
9 | ANESTHESIOL PERIOPERAT PAIN MEDSTAT SUPPO | 46547 | 0% | 100% | 1 |
10 | ANESTHESIOLOGIST | 46547 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL BIOLOGY AND MEDICINE | 3456 | 2% | 1% | 14 |
2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2613 | 4% | 0% | 25 |
3 | JOURNAL OF PAIN | 2531 | 2% | 1% | 10 |
4 | EUROPEAN UROLOGY SUPPLEMENTS | 1976 | 1% | 1% | 5 |
5 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 821 | 1% | 0% | 4 |
6 | CANCER RESEARCH | 769 | 4% | 0% | 26 |
7 | CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 663 | 2% | 0% | 10 |
8 | PAIN | 578 | 2% | 0% | 10 |
9 | CLINICAL SCIENCE | 566 | 1% | 0% | 9 |
10 | MOLECULAR CANCER THERAPEUTICS | 549 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENDOTHELIN AXIS | 523641 | 2% | 75% | 15 | Search ENDOTHELIN+AXIS | Search ENDOTHELIN+AXIS |
2 | ZIBOTENTAN | 455336 | 2% | 65% | 15 | Search ZIBOTENTAN | Search ZIBOTENTAN |
3 | ATRASENTAN | 447666 | 4% | 42% | 23 | Search ATRASENTAN | Search ATRASENTAN |
4 | ZD4054 | 394269 | 2% | 71% | 12 | Search ZD4054 | Search ZD4054 |
5 | ENDOTHELIN A RECEPTOR | 362417 | 4% | 27% | 29 | Search ENDOTHELIN+A+RECEPTOR | Search ENDOTHELIN+A+RECEPTOR |
6 | BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE | 279279 | 1% | 100% | 6 | Search BMS182874+5+DIMETHYLAMINO+N+3+4+DIMETHYL+5+ISOXAZOLYD+1+NAPHTHALENESULFONAMIDE | Search BMS182874+5+DIMETHYLAMINO+N+3+4+DIMETHYL+5+ISOXAZOLYD+1+NAPHTHALENESULFONAMIDE |
7 | ETAR | 211564 | 2% | 45% | 10 | Search ETAR | Search ETAR |
8 | ENDOTHELIN 1 | 203747 | 20% | 3% | 133 | Search ENDOTHELIN+1 | Search ENDOTHELIN+1 |
9 | ENDOTHELIN | 187756 | 21% | 3% | 140 | Search ENDOTHELIN | Search ENDOTHELIN |
10 | ENDOTHELIN B RECEPTOR | 181645 | 3% | 18% | 22 | Search ENDOTHELIN+B+RECEPTOR | Search ENDOTHELIN+B+RECEPTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ROSANO, L , SPINELLA, F , BAGNATO, A , (2013) ENDOTHELIN 1 IN CANCER: BIOLOGICAL IMPLICATIONS AND THERAPEUTIC OPPORTUNITIES.NATURE REVIEWS CANCER. VOL. 13. ISSUE 9. P. 637 -651 | 104 | 74% | 61 |
2 | BAGNATO, A , (2012) THE ENDOTHELIN AXIS AS THERAPEUTIC TARGET IN HUMAN MALIGNANCIES: PRESENT AND FUTURE.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 19. P. 2720-2733 | 88 | 68% | 5 |
3 | SMITH, TP , HAYMOND, T , SMITH, SN , SWEITZER, SM , (2014) EVIDENCE FOR THE ENDOTHELIN SYSTEM AS AN EMERGING THERAPEUTIC TARGET FOR THE TREATMENT OF CHRONIC PAIN.JOURNAL OF PAIN RESEARCH. VOL. 7. ISSUE . P. 531 -545 | 80 | 57% | 7 |
4 | BAGNATO, A , LOIZIDOU, M , PFLUG, BR , CURWEN, J , GROWCOTT, J , (2011) ROLE OF THE ENDOTHELIN AXIS AND ITS ANTAGONISTS IN THE TREATMENT OF CANCER.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 163. ISSUE 2. P. 220-233 | 67 | 61% | 57 |
5 | BAGNATO, A , SPINELLA, F , ROSANO, L , (2008) THE ENDOTHELIN AXIS IN CANCER: THE PROMISE AND THE CHALLENGES OF MOLECULARLY TARGETED THERAPY.CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 86. ISSUE 8. P. 473 -484 | 62 | 76% | 50 |
6 | SAID, N , THEODORESCU, D , (2012) PERMISSIVE ROLE OF ENDOTHELIN RECEPTORS IN TUMOR METASTASIS.LIFE SCIENCES. VOL. 91. ISSUE 13-14. P. 522-527 | 56 | 79% | 11 |
7 | IRANI, S , SALAJEGHEH, A , SMITH, RA , LAM, AKY , (2014) A REVIEW OF THE PROFILE OF ENDOTHELIN AXIS IN CANCER AND ITS MANAGEMENT.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 89. ISSUE 2. P. 314-321 | 55 | 56% | 6 |
8 | NELSON, J , BAGNATO, A , BATTISTINI, B , NISEN, P , (2003) THE ENDOTHELIN AXIS: EMERGING ROLE IN CANCER.NATURE REVIEWS CANCER. VOL. 3. ISSUE 2. P. 110-116 | 42 | 69% | 353 |
9 | SMOLLICH, M , WULFING, P , (2008) TARGETING THE ENDOTHELIN SYSTEM: NOVEL THERAPEUTIC OPTIONS IN GYNECOLOGICAL, UROLOGICAL AND BREAST CANCERS.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 8. ISSUE 9. P. 1481-1493 | 67 | 53% | 14 |
10 | BAZAN, V , GEBBIA, N , DI GAUDIO, F , FANALE, D , RIZZO, S , BRONTE, G , RUSSO, A , (2010) ANTI-ENDOTHELIN DRUGS IN SOLID TUMORS.EXPERT OPINION ON EMERGING DRUGS. VOL. 15. ISSUE 1. P. 27 -40 | 51 | 64% | 9 |
Classes with closest relation at Level 1 |